Neuron-level explainable AI for Alzheimer’s Disease assessment from fundus images
Nooshin Yousefzadeh, Charlie Tran, Adolfo Ramirez‐Zamora, Jinghua Chen, Ruogu Fang, My T. Thai
Abstract
Abstract Alzheimer’s Disease (AD) is a progressive neurodegenerative disease and the leading cause of dementia. Early diagnosis is critical for patients to benefit from potential intervention and treatment. The retina has emerged as a plausible diagnostic site for AD detection owing to its anatomical connection with the brain. However, existing AI models for this purpose have yet to provide a rational explanation behind their decisions and have not been able to infer the stage of the disease’s progression. Along this direction, we propose a novel model-agnostic explainable-AI framework, called Granu $$\underline{la}$$ <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:munder> <mml:mrow> <mml:mi>la</mml:mi> </mml:mrow> <mml:mo>̲</mml:mo> </mml:munder> </mml:math> r Neuron-le $$\underline{v}$$ <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:munder> <mml:mi>v</mml:mi> <mml:mo>̲</mml:mo> </mml:munder> </mml:math> el Expl $$\underline{a}$$ <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:munder> <mml:mi>a</mml:mi> <mml:mo>̲</mml:mo> </mml:munder> </mml:math> iner (LAVA), an interpretation prototype that probes into intermediate layers of the Convolutional Neural Network (CNN) models to directly assess the continuum of AD from the retinal imaging without the need for longitudinal or clinical evaluations. This innovative approach aims to validate retinal vasculature as a biomarker and diagnostic modality for evaluating Alzheimer’s Disease. Leveraged UK Biobank cognitive tests and vascular morphological features demonstrate significant promise and effectiveness of LAVA in identifying AD stages across the progression continuum.